23 September 2019
Rutherford Health plc
Appointment of Non-Executive Director
Rutherford Health Plc ("Rutherford" or the "Company") are pleased to announce that the Company has appointed Tim Irish to the Board as a Non-Executive Director with immediate effect.
Tim has worked in the life sciences industry for over thirty years. His career has spanned global health technology companies across Europe and North America, including GSK, GE and Philips, the latter two in senior positions responsible for medical imaging. Tim also currently holds a number of non-executive positions in health and technology related entities. Tim is currently the Vice Chair of the National Institute for Health and Care Excellence (NICE), having joined the board of NICE in April 2015. Tim Irish is currently Professor of Practice at Kings College London.
Mike Moran, chief executive officer of Rutherford Health plc, said: "We are delighted to welcome Tim to the board. His outstanding international experience will be a great asset to the company. His extensive knowledge of the opportunities and challenges across the healthcare sector will be invaluable as we continue to develop the range of services we offer cancer patients."
Tim Irish said, "I am delighted to be joining the board of such a dynamic, fast growing company and to use my experience in the healthcare industry to support its business growth. Proton Beam Therapy is now an established treatment method and I look forward to helping to make the technology more widely adopted in the UK".
Timothy Norris Irish, aged 55, is or has been a director of the following companies or a partner in the following partnerships during the last five years:
Fiagon AG Medical Technologies
National Institute for Health and Care Excellence
Pembrokeshire Retreats Limited
Quirem Medical B.V.
Anthem Schools Trust (formerly CfBT Schools Trust)
Deltex Medical Group PLC
Life Sciences Hub Wales Limited
Styrene Systems Ltd
The Centre For School Standards Limited
TTS Pharma Limited
Version Solutions Limited (formerly Patech Solutions Limited)
There is no further information that is required to be disclosed pursuant to paragraph 21 of Appendix 1 to the NEX Exchange Growth Market - Rules for Issuers.
The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.
The directors of Rutherford Health plc accept responsibility for this announcement.